Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

  1. Verde, Z.
  2. Santiago, C.
  3. Valle, B.
  4. Ana, F.-S.
  5. Bandrés, F.
  6. Calvo, E.
  7. Ruiz, J.R.
  8. Lucia, A.
  9. Gallego, F.G.
Journal:
Thrombosis and Haemostasis

ISSN: 0340-6245

Year of publication: 2009

Volume: 101

Issue: 3

Pages: 591-593

Type: Article

DOI: 10.1160/TH08-09-0578 GOOGLE SCHOLAR

Sustainable development goals